{"id":"W4393041772","doi":"10.3390/curroncol31030124","title":"Comparative Effectiveness and Safety of Trastuzumab Biosimilars to Herceptin for Adjuvant Treatment of HER2+ Breast Cancer","year":2024,"lang":"en","type":"article","venue":"Current Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Health Sciences Centre; Canadian Centre for Applied Research in Cancer Control; Sunnybrook Health Science Centre; Cancer Care Ontario","funders":"Cancer Care Ontario","keywords":"Medicine; Trastuzumab; Internal medicine; Biosimilar; Breast cancer; Oncology; Hazard ratio; Discontinuation; Retrospective cohort study; Proportional hazards model; Adjuvant; Population; Cancer; Confidence interval","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005133777,0.000185415,0.00042235,0.0004266445,0.000158326,0.0008322813,0.0003062442,0.0003610735,0.001111182],"category_scores_gemma":[0.01246486,0.0001223437,0.0009631541,0.0005430311,0.0007655125,0.0003862525,0.0003052762,0.000498988,0.00009865231],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003409785,"about_ca_system_score_gemma":0.001568579,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006189815,"about_ca_topic_score_gemma":0.00707032,"domain_scores_codex":[0.9959894,0.001755466,0.0003185421,0.0003511418,0.00141536,0.0001700405],"domain_scores_gemma":[0.9911426,0.002275557,0.004928957,0.0003787188,0.0008571551,0.0004168332],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.2952071,0.002935464,0.4747179,0.002645992,0.01151568,0.0003026578,0.0006721161,0.005049298,0.01080763,0.001145015,0.00188357,0.1931176],"study_design_scores_gemma":[0.01757546,0.1067264,0.8537756,0.0004200484,0.004953975,0.0007502852,0.0002318311,0.003057414,0.003853342,0.0005118013,0.00807983,0.00006399326],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9917561,0.006273574,0.0001453704,0.0001247132,0.00002406416,0.0000747364,0.0003789937,0.000003106788,0.001219435],"genre_scores_gemma":[0.9983429,0.0009204411,0.00009082535,0.00006379547,0.00003120553,0.00002002834,0.0004157566,0.000001226296,0.0001137955],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006189815,"threshold_uncertainty_score":0.02715033,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2116304947401476,"score_gpt":0.5426354668958013,"score_spread":0.3310049721556537,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}